Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. - Wikidata - wikimedia - TriplyDB

Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation.

Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation.

http://www.wikidata.org/entity/Q51681296

about

Influenza prevention and treatment in transplant recipients and immunocompromised hosts Fibrotic and sclerotic manifestations of chronic graft-versus-host disease Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients.Lung function and long-term complications after allogeneic hematopoietic cell transplant.Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT.Organ-specific management and supportive care in chronic graft-versus-host disease.The acute impact of a hematopoietic allograft on lung function and inflammation: a prospective observational study.Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation.How I treat late effects in adults after allogeneic stem cell transplantation.Pleuropericarditis, obliterative bronchiolitis and lymphocytic interstitial pneumonitis after allogeneic haematopoietic stem cell transplantation.Factors associated with bronchiolitis obliterans syndrome and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation.Health-related quality of life in patients who develop bronchiolitis obliterans syndrome following allo-SCT.Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage a Evaluating the impact of antithymocyte globulin on lung function at 1 year after allogeneic stem cell transplantation Chronic obstructive pulmonary disease, pollution, pulmonary vascular disease, transplantation, pleural disease, and lung cancer in AJRCCM 2003.An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantation.Pulmonary complications of solid organ and hematopoietic stem cell transplantation.Genetic variation in bactericidal/permeability-increasing protein influences the risk of developing rapid airflow decline after hematopoietic cell transplantation.Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection.Pulmonary function testing prior to hematopoietic stem cell transplantation.Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation Challenges in pulmonary fibrosis. 2: Bronchiolocentric fibrosis.Impact of chronic GVHD on late complications after hematopoietic cell transplantation.Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease.Airway dilation in bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.The lung function score and its components as predictors of overall survival and chronic graft-vs-host disease after allogeneic stem cell transplantation.Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation High-resolution CT findings of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung.Carbon monoxide diffusion capacity: how low can you go for hematopoietic cell transplantation eligibility?Pretransplant lung function, respiratory failure, and mortality after stem cell transplantation How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients

P2860

Q27011595-091CB906-F3C2-4310-87F0-F6FC786C3825 Q27024147-0C3FD387-8318-45E0-976A-7AC6ADFC443B Q30403699-A766738E-F2E3-4D98-9A62-EA990B52E1AA Q33584196-5A3A4EA7-05A5-4C8D-AA3B-B78723ED1FD8 Q33785773-402A2E43-C645-4836-A05C-0B38B936F892 Q34270868-3FAFB1BF-122E-46C0-BFAA-143EB8E75A07 Q34545875-1196902C-080F-4367-82FC-1D8D4221F227 Q34700473-DA1E8F38-2B9B-42E7-91CB-C1E44D75CFA4 Q34707208-FEC90B26-7478-4182-A5A4-662C2DD352E9 Q34710745-B7CB78ED-1DC9-412C-966C-090F5D17F4CE Q35038942-F73DE4A1-6248-43B2-B33E-46C6B5807985 Q35153996-7C8BCE76-07D4-415E-A6EB-9E65848DC80C Q35293711-59CB4A13-EBC5-40CA-A417-198A8839621E Q35549037-C54CD4F3-36ED-4BBD-A7AD-C93F14A07528 Q35574785-077DAA33-1739-49BE-9BBA-5F013E867FCB Q35626624-6980805B-F9B6-40BC-AE45-8FE0CB0F19F8 Q35694784-AC9EB5AD-9246-485B-BEB7-5EF1A83D5C28 Q35714438-F1BBF326-1805-46A4-80B3-5D89523D9C4E Q35740698-9F1C24CF-7EC1-4767-9A5C-3E91B90E0AAF Q35849483-97B46674-564A-4683-AB9B-76E9E642092E Q35989482-0E5F3FD9-6AF6-4773-9DC3-B1C282CA83A4 Q36011668-89D05F23-CA46-498D-9363-794586A4DFAC Q36078180-C7632049-26FA-4857-AD83-7ACED37E8589 Q36178151-E451E11C-42A5-45B4-A840-37174B62FCA7 Q36225775-3153E684-6D5F-44F3-9C8B-64D4CD53A32C Q36270126-8D7CF111-8BD0-45C2-90C8-E2F262C653B0 Q36461789-180CCAB1-D523-4785-B244-F4EB6BB97241 Q36527645-13307C7B-A459-4E5D-972C-1DBA0B2D5F8E Q36541552-B1B709CE-8770-4561-B731-0B04AE444A70 Q36707835-057230E1-B1F2-4A84-BD05-0479D4F08C99 Q36712018-C2243DF8-5157-437A-A1DF-5E9241F03AEB Q36766324-2E6EEF7A-63BB-4A89-8055-37C97F7BA890 Q36965855-F086EB51-46CC-4520-9378-94D1E3B4CCAA Q37093836-BF945DB5-3CC7-4AEF-AAE9-C5345F58B5D0 Q37146140-1261A7E3-21EA-4411-A906-A77F6322FCC4 Q37177449-1266DE92-9700-4ABE-A514-532580065885 Q37282816-2696E009-DFCD-4D6F-82D3-2E514B9C34AC Q37609903-2F1F363C-F814-4895-AB01-B300294758DD Q37680499-362681CE-F8D2-4D71-B7F3-A8E5A66A4385 Q37703430-00C9E1CD-9C15-43EC-8E1C-1B7C62D2B70F

P2860

Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation.

http://www.wikidata.org/entity/Q51681296

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Airflow obstruction after myel ...... tic stem cell transplantation.

@en

Airflow obstruction after myel ...... tic stem cell transplantation.

@nl

type

label

Airflow obstruction after myel ...... tic stem cell transplantation.

@en

Airflow obstruction after myel ...... tic stem cell transplantation.

@nl

prefLabel

Airflow obstruction after myel ...... tic stem cell transplantation.

@en

Airflow obstruction after myel ...... tic stem cell transplantation.

@nl

P1433

Q51681296-211BC359-7362-4DB4-9D35-683510E88B1C

P1476

Q51681296-C76F1FC9-9423-40F6-A41A-E31151495244

P2093

Q51681296-0B573368-CEDC-4DD2-8F17-5FA06C97B5E6

Q51681296-478DCFF9-DBB9-4F37-8FDE-311381CC1C19

Q51681296-4B70CCCF-32C3-4AB1-8C58-D8C439C7BF85

Q51681296-77C38AF6-459F-4989-8A7B-0DAB473846A7

Q51681296-798EF875-CC94-450C-8379-53B676A23D7E

Q51681296-956F61A3-C7E9-4F57-93CE-0A0C8CA68CF8

Q51681296-B6958E99-59DB-4990-AFA3-063B92486F49

P2860

Q51681296-0310A7D5-00D4-48F1-A7E7-1E67F5253C83

Q51681296-06F27F3A-14E8-4F2B-87D3-6DD277EFC36C

Q51681296-07B60068-E594-41BD-8A0F-86B21B50793A

Q51681296-0E793067-E61A-4863-A450-EFD7F9834BBF

Q51681296-192A53BF-0292-4A7E-8E2F-A23899C1B478

Q51681296-19F3EE66-93A3-4873-9E44-E3E0D9F977E8

Q51681296-3ABC6D4D-C9DF-4089-994D-4972CD9170B1

Q51681296-49017D85-0510-474F-9FAE-D14C06D73C8C

Q51681296-6945AE2F-34E5-4850-814F-F4DD4C59F54F

Q51681296-74845DB2-B685-403D-AAF2-0F9486E9F057

P304

Q51681296-62C8351E-2E24-4DBC-9E8E-BC7024DC5949

P31

Q51681296-8F42D951-B0D1-4651-B050-40E111691D1F

P356

Q51681296-FFE94174-4BC7-4C3A-8F9C-15684DB32278

P407

Q51681296-C6C6A220-79EE-4CB5-AAD6-63EA45E229B9

P433

Q51681296-C0A25E5E-6F0F-4612-9AF9-EF4BA448D85A

P478

Q51681296-7C549074-E6D6-4046-9A0E-702CE7D9F2BA

P577

Q51681296-B56AD1B7-38CE-476F-8D09-997BBB452FDF

P698

Q51681296-D9F438DF-1BEF-47FA-90ED-F06CD3C063FE

P356

RCCM.200212-1468OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Airflow obstruction after myel ...... tic stem cell transplantation.

@en

P2093

Jason W Chien

http://www.w3.org/2001/XMLSchema#string

Joan G Clark

http://www.w3.org/2001/XMLSchema#string

Mary E Flowers

http://www.w3.org/2001/XMLSchema#string

Paul J Martin

http://www.w3.org/2001/XMLSchema#string

Susan R Heckbert

http://www.w3.org/2001/XMLSchema#string

Ted A Gooley

http://www.w3.org/2001/XMLSchema#string

W Garrett Nichols

http://www.w3.org/2001/XMLSchema#string

P2860

Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers

Nonparametric Estimation from Incomplete Observations

Pulmonary function changes in long-term survivors of bone marrow transplantation

What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes

Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone.

Pathophysiology and treatment of graft-versus-host disease.

Trends in transplantation of hematopoietic stem cells from unrelated donors.

Understanding the alloresponse: new approaches to graft-versus-host disease prevention.

Pulmonary function abnormalities after allogeneic marrow transplantation: a systematic review and assessment of an existing predictive instrument.

Airways obstruction associated with graft versus host disease after bone marrow transplantation

P304

208-214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200212-1468OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

168

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12649126

http://www.w3.org/2001/XMLSchema#string